UB Paderborn / Katalog / Suche / in CDI

Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study

NeuroImage clinical, 2020-01, Vol.28, p.102504-102504, Article 102504

2020

Volltextzugriff (PDF)

224: [18 F]HX4 PET imaging of tumour hypoxia in HNSCC patients

Radiotherapy and oncology, 2014-02, Vol.110, p.S109-S109

2014

Volltextzugriff (PDF)

(R)- and (S)-[ 11C]verapamil as PET-tracers for measuring P-glycoprotein function: in vitro and in vivo evaluation

Nuclear medicine and biology, 2003-10, Vol.30 (7), p.747-751

2003

Volltextzugriff (PDF)

William C. Eckelman, an icon of radiopharmaceutical sciences

Nuclear medicine and biology, 2021-01, Vol.92, p.1-1

Windhorst, A.D.

2021

Volltextzugriff (PDF)

PO-0950: Nitroglycerin decreases the hypoxic fraction in non-small cell lung cancer: an imaging study using [18F]HX4 PET

Radiotherapy and oncology, 2014, Vol.111, p.S126-S126

2014

Volltextzugriff (PDF)

PD-0355: [18F]HX4 hypoxia PET imaging gives complementary information to [18F]FDG PET in NSCLC patients

Radiotherapy and oncology, 2014, Vol.111, p.S136-S136

2014

Volltextzugriff (PDF)

P.4.032 Neuroinflammation in temporal cortex in schizophrenia patients

European neuropsychopharmacology, 2013-03, Vol.23, p.S93-S94

2013

Volltextzugriff (PDF)

245 Towards Prediction of Efficacy of Chemotherapy: a Proof of Concept Study in Lung Cancer Patients Using [11C]docetaxel and Positron Emission Tomography

European journal of cancer (1990), 2012-11, Vol.48, p.75-76

2012

Volltextzugriff (PDF)

P.1.g.069 Aberrant ligand–receptor dynamics of the muscarine-M1 agonist AF150(S)

European neuropsychopharmacology, 2013-10, Vol.23, p.S230-S230

2013

Volltextzugriff (PDF)

Synthesis and biodistribution of [11C]R107474, a new radiolabeled α2-adrenoceptor antagonist

Bioorganic & medicinal chemistry, 2006-07, Vol.14 (13), p.4526-4534

2006

Volltextzugriff (PDF)

P.1.e.026 [11C]AF150(S): a putative agonist PET ligand for in vivo imaging of the M1 muscarinic acetylcholine receptor

European neuropsychopharmacology, 2010, Vol.20, p.S302-S303

2010

Volltextzugriff (PDF)

P.5.b.001 Longitudinal [11C]PIB and [18F]FDDNP PET studies on memory in patients and controls

European neuropsychopharmacology, 2010, Vol.20, p.S560-S561

2010

Volltextzugriff (PDF)

Synthesis and biodistribution of [11C]R116301, a promising PET ligand for central NK1 receptors

Bioorganic & medicinal chemistry, 2005-03, Vol.13 (5), p.1579-1586

2005

Volltextzugriff (PDF)

P.3.f.007 Microglia is widespread activated in recent onset schizophrenia: evidence from PET and post mortem studies

European neuropsychopharmacology, 2009, Vol.19, p.S585-S585

2009

Volltextzugriff (PDF)

The past, present, and the promise of the future of nuclear medicine and biology

Nuclear medicine and biology, 2017-12, Vol.55, p.47-48

2017

Volltextzugriff (PDF)

Grey zone amyloid burden affects memory function: the SCIENCe project

European journal of nuclear medicine and molecular imaging, 2021-03, Vol.48 (3), p.747-756

2021

Volltextzugriff (PDF)

Corrigendum to “SSP-27: 89Zr-immuno-PET of a novel bispecific amyloid β monoclonal antibody reveals improved and high specific brain uptake” [Nucl Med Biol (2020) Volumes 96–97, Supplement. S30-S31]

Nuclear medicine and biology, 2022-01, Vol.104-105, p.65-65

2022

Volltextzugriff (PDF)

Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study

European journal of nuclear medicine and molecular imaging, 2022-04, Vol.49 (5), p.1731-1742

2022

Volltextzugriff (PDF)

576 In vivo pharmacokinetics of [11C]docetaxel in lung cancer patients

European journal of cancer supplements, 2010, Vol.8 (7), p.182-182

2010

Volltextzugriff (PDF)

Whole body PD-L1 PET in patients with NSCLC and melanoma

Journal of clinical oncology, 2018-02, Vol.36 (5_suppl), p.139-139

2018

Volltextzugriff (PDF)

PET/CT and near-infrared fluorescence imaging of tumors using a cRGD-based multimodal imaging agent

HPB (Oxford, England), 2018-09, Vol.20, p.S774-S774

2018

Volltextzugriff (PDF)

MA 05.07 Whole Body PD-1 and PD-L1 PET in Pts with NSCLC

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1817-S1817

2017

Volltextzugriff (PDF)

Quantitative accuracy and 28-day test-retest repeatability of parametric methods for [11C]UCB-J PET

Physica medica, 2021-12, Vol.92, p.S95-S96

2021

Volltextzugriff (PDF)

OD85 - Quantitative accuracy and 28-day test-retest repeatability of parametric methods for [11C]UCB-J PET

Physica medica, 2021-12, Vol.92, p.S95-S96

2021

Volltextzugriff (PDF)

Subchronic treatment with phencyclidine in adolescence leads to impaired exploratory behavior in adult rats without altering social interaction or N-methyl-D-aspartate receptor binding levels

Journal of neuroscience research, 2014-11, Vol.92 (11), p.1599-1607

2014

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study

224: [18 F]HX4 PET imaging of tumour hypoxia in HNSCC patients

(R)- and (S)-[ 11C]verapamil as PET-tracers for measuring P-glycoprotein function: in vitro and in vivo evaluation

William C. Eckelman, an icon of radiopharmaceutical sciences

PO-0950: Nitroglycerin decreases the hypoxic fraction in non-small cell lung cancer: an imaging study using [18F]HX4 PET

PD-0355: [18F]HX4 hypoxia PET imaging gives complementary information to [18F]FDG PET in NSCLC patients

P.4.032 Neuroinflammation in temporal cortex in schizophrenia patients

245 Towards Prediction of Efficacy of Chemotherapy: a Proof of Concept Study in Lung Cancer Patients Using [11C]docetaxel and Positron Emission Tomography

P.1.g.069 Aberrant ligand–receptor dynamics of the muscarine-M1 agonist AF150(S)

Synthesis and biodistribution of [11C]R107474, a new radiolabeled α2-adrenoceptor antagonist

P.1.e.026 [11C]AF150(S): a putative agonist PET ligand for in vivo imaging of the M1 muscarinic acetylcholine receptor

P.5.b.001 Longitudinal [11C]PIB and [18F]FDDNP PET studies on memory in patients and controls

Synthesis and biodistribution of [11C]R116301, a promising PET ligand for central NK1 receptors

P.3.f.007 Microglia is widespread activated in recent onset schizophrenia: evidence from PET and post mortem studies

The past, present, and the promise of the future of nuclear medicine and biology

Grey zone amyloid burden affects memory function: the SCIENCe project

Corrigendum to “SSP-27: 89Zr-immuno-PET of a novel bispecific amyloid β monoclonal antibody reveals improved and high specific brain uptake” [Nucl Med Biol (2020) Volumes 96–97, Supplement. S30-S31]

Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study

576 In vivo pharmacokinetics of [11C]docetaxel in lung cancer patients

Whole body PD-L1 PET in patients with NSCLC and melanoma

PET/CT and near-infrared fluorescence imaging of tumors using a cRGD-based multimodal imaging agent

MA 05.07 Whole Body PD-1 and PD-L1 PET in Pts with NSCLC

Quantitative accuracy and 28-day test-retest repeatability of parametric methods for [11C]UCB-J PET

OD85 - Quantitative accuracy and 28-day test-retest repeatability of parametric methods for [11C]UCB-J PET

Subchronic treatment with phencyclidine in adolescence leads to impaired exploratory behavior in adult rats without altering social interaction or N-methyl-D-aspartate receptor binding levels

Suchergebnisse filtern